| Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study H Gacaferi, GS Collaborative, COVIDSurg Collaborative Anaesthesia 76 (6), 2021 | 532* | 2021 |
| SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study COVIDSurg Collaborative, GlobalSurg Collaborative British Journal of Surgery 108 (9), 1056-1063, 2021 | 117 | 2021 |
| Cell-intrinsic PD-1 promotes proliferation in pancreatic cancer by targeting CYR61/CTGF via the hippo pathway N Pu, S Gao, H Yin, J Li, W Wu, Y Fang, L Zhang, Y Rong, X Xu, D Wang, ... Cancer letters 460, 42-53, 2019 | 74 | 2019 |
| CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancer Q Chen, N Pu, H Yin, J Zhang, G Zhao, W Lou, W Wu Journal of cellular and molecular medicine 24 (15), 8674-8686, 2020 | 73 | 2020 |
| SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. C COVIDSurg, C GlobalSurg Anaesthesia 77 (1), 28-39, 2022 | 68 | 2022 |
| Clinical course and risk factors for recurrence of positive SARS-CoV-2 RNA: a retrospective cohort study from Wuhan, China J Chen, X Xu, J Hu, Q Chen, F Xu, H Liang, N Liu, H Zhu, J Lan, L Zhou, ... Aging (Albany NY) 12 (17), 16675, 2020 | 60 | 2020 |
| SARS‐CoV‐2 infection and venous thromboembolism after surgery: an international prospective cohort study COVIDSurg Collaborative, GlobalSurg Collaborative, D Nepogodiev, ... Anaesthesia 77 (1), 28-39, 2022 | 59 | 2022 |
| Comparison of prognostic prediction between nomogram based on lymph node ratio and AJCC 8th staging system for patients with resected pancreatic head carcinoma: a SEER analysis N Pu, J Li, Y Xu, W Lee, Y Fang, X Han, G Zhao, L Zhang, A Nuerxiati, ... Cancer management and research, 227-238, 2018 | 49 | 2018 |
| Alkaline phosphatase-to-albumin ratio as a prognostic indicator in pancreatic ductal adenocarcinoma after curative resection N Pu, S Gao, Y Xu, G Zhao, Y Lv, A Nuerxiati, J Li, D Wang, X Xu, T Kuang, ... Journal of Cancer 8 (16), 3362, 2017 | 49 | 2017 |
| CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer N Pu, G Zhao, H Yin, J Li, A Nuerxiati, D Wang, X Xu, T Kuang, D Jin, ... Journal of Translational Medicine 16, 1-13, 2018 | 43 | 2018 |
| Effects of pre‐operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study COVIDSurg Collaborative, GlobalSurg Collaborative, D Nepogodiev, ... Anaesthesia 76 (11), 1454-1464, 2021 | 42 | 2021 |
| Improved assessment of response status in patients with pancreatic cancer treated with neoadjuvant therapy using somatic mutations and liquid biopsy analysis L Yin, N Pu, E Thompson, Y Miao, C Wolfgang, J Yu Clinical Cancer Research 27 (3), 740-748, 2021 | 41 | 2021 |
| One hundred twenty-one resected solid pseudopapillary tumors of the pancreas: an 8-year single-institution experience at Zhongshan Hospital, Shanghai, China Y Xu, G Zhao, N Pu, A Nuerxiati, Y Ji, L Zhang, Y Rong, W Lou, D Wang, ... Pancreas 46 (8), 1023-1028, 2017 | 36 | 2017 |
| Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4/MyD88/AKT/NF-κB pathway in pancreatic cancer H Yin, N Pu, Q Chen, J Zhang, G Zhao, X Xu, D Wang, T Kuang, D Jin, ... Cell death & disease 12 (11), 1033, 2021 | 33 | 2021 |
| Combined test of serum CgA and NSE improved the power of prognosis prediction of NF-pNETs Y Lv, X Han, C Zhang, Y Fang, N Pu, Y Ji, D Wang, X Xuefeng, W Lou Endocrine Connections 7 (1), 169-178, 2018 | 32 | 2018 |
| Downregulation of miR-1 in colorectal cancer promotes radioresistance and aggressive phenotypes Y Wu, N Pu, W Su, X Yang, C Xing Journal of Cancer 11 (16), 4832, 2020 | 30 | 2020 |
| Genetic landscape of prognostic value in pancreatic ductal adenocarcinoma microenvironment N Pu, Q Chen, S Gao, G Liu, Y Zhu, L Yin, H Hu, L Wei, Y Wu, S Maeda, ... Annals of Translational Medicine 7 (22), 2019 | 28 | 2019 |
| Recurrence in patients achieving pathological complete response after neoadjuvant treatment for advanced pancreatic cancer AB Blair, LD Yin, N Pu, J Yu, VP Groot, NS Rozich, AA Javed, L Zheng, ... Annals of surgery 274 (1), 162-169, 2021 | 27 | 2021 |
| PD-1 immunotherapy in pancreatic cancer: current status N Pu, W Lou, J Yu Journal of Pancreatology 2 (01), 6-10, 2019 | 27 | 2019 |
| Neutralizing TGF-β promotes anti-tumor immunity of dendritic cells against pancreatic cancer by regulating T lymphocytes N Pu, G Zhao, S Gao, Y Cui, Y Xu, Y Lv, A Nuerxiati, W Wu Central European Journal of Immunology 43 (2), 123-131, 2018 | 24 | 2018 |
